Tourmaline Bio, Inc. - TRML
Sector:
Healthcare
· Industry:
Biological Products, (No Diagnostic Substances)
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q3 2025
· Q2 2025
Value (USD)
Total reported value ($000)
$997M
QoQ value delta ($000)
+$629.9M
(+171.59%)
Implied price effect (QoQ)
+199.14%
Shares
Total shares
20,846,255
QoQ shares delta
-2,115,103
(-9.21%)
Total shares held by funds (by quarter)
Market chart (TRML)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q3 2025)
Top 25 only
Full list
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| Avoro Capital Advisors LLC | 122,232 | 2,555,555 | 1.58% |
| QVT Financial LP | 103,057 | 2,154,653 | 7.27% |
| BlackRock, Inc. | 72,595 | 1,517,777 | 0.0% |
| TCG Crossover Management, LLC | 62,742 | 1,311,783 | 3.09% |
| PFIZER INC | 60,849 | 1,272,214 | 13.91% |
| VANGUARD GROUP INC | 55,750 | 1,165,607 | 0.0% |
| FIL Ltd | 49,154 | 1,027,690 | 0.04% |
| Magnetar Financial LLC | 46,209 | 966,129 | 0.28% |
| First Trust Capital Management L.P. | 33,278 | 695,757 | 2.15% |
| TIG Advisors, LLC | 29,643 | 619,763 | 1.76% |
| Vivo Capital, LLC | 28,309 | 591,882 | 2.28% |
| ALLIANCEBERNSTEIN L.P. | 25,826 | 539,961 | 0.01% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 21,779 | 455,360 | 1.89% |
| GEODE CAPITAL MANAGEMENT, LLC | 21,716 | 453,952 | 0.0% |
| STATE STREET CORP | 19,895 | 415,970 | 0.0% |
| GOLDMAN SACHS GROUP INC | 18,019 | 376,738 | 0.0% |
| AQR Arbitrage LLC | 17,925 | 374,785 | 0.46% |
| ACUTA CAPITAL PARTNERS, LLC | 12,840 | 268,451 | 13.27% |
| MORGAN STANLEY | 12,057 | 252,093 | 0.0% |
| NAN FUNG TRINITY (HK) Ltd | 10,861 | 227,090 | 1.08% |
| Versor Investments LP | 10,389 | 217,221 | 1.91% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 9,383 | 196,177 | 0.57% |
| MILLENNIUM MANAGEMENT LLC | 9,117 | 190,625 | 0.0% |
| GLAZER CAPITAL, LLC | 8,617 | 180,155 | 0.29% |
| UBS Group AG | 8,531 | 178,371 | 0.0% |